請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/38282
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李建國 | |
dc.contributor.author | Wei Lee | en |
dc.contributor.author | 李瑋 | zh_TW |
dc.date.accessioned | 2021-06-13T16:29:27Z | - |
dc.date.available | 2005-07-20 | |
dc.date.copyright | 2005-07-20 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-07-12 | |
dc.identifier.citation | Abell, K., Bilancio, A., Clarkson, R. W., Tiffen, P. G., Altaparmakov, A. I., Burdon, T. G., Asano, T., Vanhaesebroeck, B., and Watson, C. J. (2005). Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol 7, 392-398.
Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., and Poli, V. (2001). Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Mol Cell Biol 21, 1621-1632. Boer, U., Fennekohl, A., and Puschel, G. P. (2003). Sensitization by interleukin-6 of rat hepatocytes to tumor necrosis factor alpha-induced apoptosis. J Hepatol 38, 728-735. Bogdanos, D. P., Mieli-Vergani, G., and Vergani, D. (2000). Virus, liver and autoimmunity. Dig Liver Dis 32, 440-446. Bonder, C. S., Ajuebor, M. N., Zbytnuik, L. D., Kubes, P., and Swain, M. G. (2004). Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 172, 45-53. Cao, Q., Batey, R., Pang, G., Russell, A., and Clancy, R. (1998). IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol Cell Biol 76, 542-549. Chapman, R. S., Lourenco, P. C., Tonner, E., Flint, D. J., Selbert, S., Takeda, K., Akira, S., Clarke, A. R., and Watson, C. J. (1999). Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13, 2604-2616. Chen, X. P., Losman, J. A., and Rothman, P. (2000). SOCS proteins, regulators of intracellular signaling. Immunity 13, 287-290. Croker, B. A., Krebs, D. L., Zhang, J. G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Forster, I., Clausen, B. E., et al. (2003). SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4, 540-545. Darnell, J. E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635. Debonera, F., Aldeguer, X., Shen, X., Gelman, A. E., Gao, F., Que, X., Greenbaum, L. E., Furth, E. E., Taub, R., and Olthoff, K. M. (2001). Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J Surg Res 96, 289-295. Dieter, P., Hempel, U., Kamionka, S., Kolada, A., Malessa, B., Fitzke, E., and Tran-Thi, T. A. (1999). Prostaglandin E2 affects differently the release of inflammatory mediators from resident macrophages by LPS and muramyl tripeptides. Mediators Inflamm 8, 295-303. Emmerich, C., Helliwell, J. R., Redshaw, M., Naismith, J. H., Harrop, S. J., Raftery, J., Kalb, A. J., Yariv, J., Dauter, Z., and Wilson, K. S. (1994). High-resolution structures of single-metal-substituted concanavalin A: the Co,Ca-protein at 1.6 A and the Ni,Ca-protein at 2.0 A. Acta Crystallogr D Biol Crystallogr 50, 749-756. Gantner, F., Leist, M., Lohse, A. W., Germann, P. G., and Tiegs, G. (1995). Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21, 190-198. Haga, S., Terui, K., Zhang, H. Q., Enosawa, S., Ogawa, W., Inoue, H., Okuyama, T., Takeda, K., Akira, S., Ogino, T., et al. (2003). Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 112, 989-998. Hamodrakas, S. J., Kanellopoulos, P. N., Pavlou, K., and Tucker, P. A. (1997). The crystal structure of the complex of concanavalin A with 4'-methylumbelliferyl-alpha-D-glucopyranoside. J Struct Biol 118, 23-30. Heneghan, M. A., and McFarlane, I. G. (2002). Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35, 7-13. Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V. A., and Gao, B. (2002). Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110, 1503-1513. Hong, F., Kim, W. H., Tian, Z., Jaruga, B., Ishac, E., Shen, X., and Gao, B. (2002). Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21, 32-43. Ihle, J. N. (1996). STATs: signal transducers and activators of transcription. Cell 84, 331-334. Jaruga, B., Hong, F., Sun, R., Radaeva, S., and Gao, B. (2003). Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171, 3233-3244. Kaneko, Y., Harada, M., Kawano, T., Yamashita, M., Shibata, Y., Gejyo, F., Nakayama, T., and Taniguchi, M. (2000). Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191, 105-114. Kato, M., Ikeda, N., Matsushita, E., Kaneko, S., and Kobayashi, K. (2001). Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by Concanavalin A. Hepatol Res 20, 232-243. Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M., and Yoshimura, A. (2002). SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583-591. Kisseleva, T., Bhattacharya, S., Braunstein, J., and Schindler, C. W. (2002). Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285, 1-24. Kita, H., Mackay, I. R., Van De Water, J., and Gershwin, M. E. (2001). The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120, 1485-1501. Klein, C., Wustefeld, T., Assmus, U., Roskams, T., Rose-John, S., Muller, M., Manns, M. P., Ernst, M., and Trautwein, C. (2005). The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 115, 860-869. Kovalovich, K., Li, W., DeAngelis, R., Greenbaum, L. E., Ciliberto, G., and Taub, R. (2001). Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276, 26605-26613. Lee, C. K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R. A., and Levy, D. E. (2002). STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63-72. Leonard, W. J., and O'Shea, J. J. (1998). Jaks and STATs: biological implications. Annu Rev Immunol 16, 293-322. Leu, J. I., Crissey, M. A., Leu, J. P., Ciliberto, G., and Taub, R. (2001). Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 21, 414-424. Levy, D. E., and Darnell, J. E., Jr. (2002). Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3, 651-662. Levy, D. E., and Lee, C. K. (2002). What does Stat3 do? J Clin Invest 109, 1143-1148. Li, W., Liang, X., Kellendonk, C., Poli, V., and Taub, R. (2002). STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277, 28411-28417. Loffreda, S., Rai, R., Yang, S. Q., Lin, H. Z., and Diehl, A. M. (1997). Bile ducts and portal and central veins are major producers of tumor necrosis factor alpha in regenerating rat liver. Gastroenterology 112, 2089-2098. Massaguer, A., Perez-Del-Pulgar, S., Engel, P., Serratosa, J., Bosch, J., and Pizcueta, P. (2002). Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin. J Leukoc Biol 72, 262-270. Matsumoto, G., Tsunematsu, S., Tsukinoki, K., Ohmi, Y., Iwamiya, M., Oliveira-dos-Santos, A., Tone, D., Shindo, J., and Penninger, J. M. (2002). Essential role of the adhesion receptor LFA-1 for T cell-dependent fulminant hepatitis. J Immunol 169, 7087-7096. Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., and Fujiwara, H. (1994). T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179, 1529-1537. Naka, T., Fujimoto, M., and Kishimoto, T. (1999). Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem Sci 24, 394-398. Nicola, N. A., Nicholson, S. E., Metcalf, D., Zhang, J. G., Baca, M., Farley, A., Willson, T. A., Starr, R., Alexander, W., and Hilton, D. J. (1999). Negative regulation of cytokine signaling by the SOCS proteins. Cold Spring Harb Symp Quant Biol 64, 397-404. O'Shea, J. J., Gadina, M., and Schreiber, R. D. (2002). Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 Suppl, S121-131. Okamoto, T., Nakano, Y., Asakura, W., Kobayashi, T., Tsuzuike, N., and Hara, K. (1998). Expression of cytokine mRNA in extrahepatic organs in a mouse concanavalin A-hepatitis model. Jpn J Pharmacol 77, 219-225. Radaeva, S., Sun, R., Pan, H. N., Hong, F., and Gao, B. (2004). Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39, 1332-1342. Rehermann, B., and Chisari, F. V. (2000). Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 242, 299-325. Sass, G., Shembade, N. D., and Tiegs, G. (2005). Tumour necrosis factor alpha (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signalling. Biochem J 385, 537-544. Sato, T., Saito, R., Jinushi, T., Tsuji, T., Matsuzaki, J., Koda, T., Nishimura, S., Takeshima, H., and Nishimura, T. (2004). IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. Biochem Biophys Res Commun 314, 468-475. Schindler, C. (1999). Cytokines and JAK-STAT signaling. Exp Cell Res 253, 7-14. Schumann, J., Wolf, D., Pahl, A., Brune, K., Papadopoulos, T., van Rooijen, N., and Tiegs, G. (2000). Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 157, 1671-1683. Schuringa, J. J., Jonk, L. J., Dokter, W. H., Vellenga, E., and Kruijer, W. (2000). Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Biochem J 347 Pt 1, 89-96. Seino, K., Kayagaki, N., Takeda, K., Fukao, K., Okumura, K., and Yagita, H. (1997). Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113, 1315-1322. Sharon, N., and Lis, H. (2004). History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14, 53R-62R. Sun, R., Tian, Z., Kulkarni, S., and Gao, B. (2004). IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J Immunol 172, 5648-5655. Tagawa, Y., Sekikawa, K., and Iwakura, Y. (1997). Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159, 1418-1428. Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H., and Okumura, K. (2000). Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 97, 5498-5503. Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., and Akira, S. (1998). Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161, 4652-4660. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., and Akira, S. (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 94, 3801-3804. Tiegs, G., Hentschel, J., and Wendel, A. (1992). A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90, 196-203. Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., and Jove, R. (2001). Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 276, 45443-45455. Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003). IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4, 551-556. Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H., and Yoshimura, A. (2004). SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med 199, 1701-1707. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/38282 | - |
dc.description.abstract | STAT3 基因在起始肝臟發育以及再生功能中扮演重要的角色。然而,STAT3 在肝炎反應中的角色仍然不清楚。為了瞭解 STAT3 在 Con A 所引發的肝炎反應中扮演的角色,我們用只剔除肝臟細胞 STAT3 基因(ST3KO)的老鼠來做為動物模式的研究材料。在 Con A 的刺激下,缺少 STAT3 的老鼠血清裡的 ALT 以及 AST 值較正常的老鼠為低,從肝臟切片染色中我們也發現較少的肝臟受損,而且,肝臟細胞的 caspase-3 活性也較正常的老鼠低,另外,這種老鼠在高劑量 Con A 的刺激下所誘發的死亡率也較低,這些結果皆指出 STAT3 在 Con A 引發的老鼠肝炎的動物模式中扮演促進發炎的角色。
接著我們想進一步研究這種缺少 STAT3 的老鼠抑制 Con A 引發肝炎反應的機制。首先,我們發現在正常老鼠與 ST3KO 老鼠肝臟裡的各種白血球(IHL)比例及數目,如 CD4+ T細胞,自然殺手T (NKT)細胞,顆粒球細胞 (granulocytes) 以及肝臟的巨噬細胞 (Kupffer cells),在 Con A 刺激前或者刺激後都相當類似;其次, Con A 刺激後血清中促進發炎的細胞激素, 如 IFN-γ、TNF-α、IL-4,以及血清中的抑制發炎的細胞激素,如 IL-10、IL-6 的濃度及肝臟中這些激素的 mRNA 表現量在正常老鼠及 ST3KO 老鼠中都是相似的。這些結果暗示肝臟細胞的 STAT3 被剔除後並不影響 effector 細胞被徵召回肝臟,也不會影響細胞激素的產生及釋放。這個推論也由正常老鼠及 ST3KO 老鼠有相似的脾臟受損程度的結果中獲得支持,這個結果進一步證明 ST3KO 老鼠的淋巴球有正常的功能。 為了探討 ST3KO 老鼠在 Con A 模式中有較低的肝炎反應,是否因為缺少 STAT3 的肝細胞可以抵抗細胞激素誘發的細胞死亡。我們將原始的肝細胞 (primary hepatocytes) 以不同的細胞激素去刺激,結果發現 TNF-α/Actinomycin D 誘發的細胞死亡程度在缺少 STAT3 的肝細胞中較低。再者,IL6 造成增強 TNF-α/Actinomycin D 引起的細胞死亡的機制在缺少 STAT3 的肝細胞中則是受到阻礙。 有趣的是,在 Con A 刺激後肝臟裡的 SOCS 被引發的量在 ST3KO 老鼠中是不正常的。在 ST3KO 老鼠的肝臟中, SOCS3 被引發的量遠比正常的老鼠低,而 SOCS1 被引發的量比正常的老鼠高。這些結果暗示,在 ST3KO 老鼠中這些不正常的 SOCS 被引發量可能會影響細胞激素的訊號傳遞,進而抑制 Con A 引發的肝炎反應。 綜合以上的發現,這些結果指出在 Con A 引發的老鼠肝炎動物模式中 STAT3 透過 IL-6-STAT3 的訊號傳遞增強 TNF-α 引起的細胞死亡,因而扮演了正向調控因子的角色,其中一個可能的機制是透過 STAT3 下游的 SOCS1/SOCS3 調控細胞激素的訊號傳遞。 | zh_TW |
dc.description.abstract | STAT3 is an essential molecule for the initiation of liver development and regeneration. However the role of STAT3 in liver damage remains unclear. In order to characterize the role of STAT3 in concanavalin A (Con A)-induced model of immune-mediated hepatitis, ST3KO mice were used. After Con A treatment, reduced serum ALT/AST levels, liver injury, apoptosis and high-dose-induced lethality were observed in ST3KO mice as opposed to WT mice, suggesting that STAT3 had a pro-apoptotic role in hepatocytes in Con A-induced hepatitis.
The mechanism of ST3KO mice resistant to Con A-induced hepatitis was further studied. First of all, the percentage and numbers of IHLs, including CD4+ T, NKT, granulocytes and kupffer cells were comparable in WT and ST3KO mice before and after Con A treatment. Secondly, mRNA levels in the liver and protein levels in the serum of pro-inflammatory cytokines such as IL-4, IFN-γ and TNF-α and anti-inflammatory cytokines such as IL-6 and IL-10 were similar between WT and ST3KO mice after Con A treatment. These findings suggested that the recruitment of effector cells to liver and the production and release of cytokines were normal in the absence of STAT3. In line with these results, similar severity of pathology was observed in the spleen, where STAT3 was not deleted. These results suggested that lymphocytes of ST3KO mice were functional. To investigate if the impaired Con A-induced hepatitis was due to resistance of cytokine-induced apoptosis in the hepatocytes lacking STAT3, primary hepatocytes were incubated with different apoptosis-inducing cytokines in vitro. Decreased TNF-α/Actinomycin D-induced apoptosis was found in STAT3 knockout hepatocytes. Furthermore, IL-6-mediated enhancement of TNF-α/Actinomycin D-induced apoptosis was completely blocked in the absence of STAT3. Interestingly, the levels of SOCS molecules were dysregulated in the liver of ST3KO mice after Con A treatment. Impaired SOCS3 and prolonged SOCS1 induction were detected in ST3KO mice, implying these atypical SOCS production might be affecting cytokine signaling and contribute to impaired Con A-induced hepatitis in ST3KO mice. Taken together, these results suggested that STAT3 is a positive regulator for Con A-induced hepatitis by regulating the response through IL-6-STAT3 signaling to enhance TNF-α-induced apoptosis. One of the mechanisms is through its downstream targets such as SOCS1/SOCS3 to regulate cytokine responses. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T16:29:27Z (GMT). No. of bitstreams: 1 ntu-94-R92449011-1.pdf: 4151070 bytes, checksum: 8e74e43621add7919057cef3865067b5 (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | Chapter I Introduction…………………………............................................. 1
Part 1Background…………………………………………………………………. 1 1.1 Concanavalin A…...…………………………………………………….…... 1 1.2 T cell mediated hepatitis inducing by Con A………………………...……... 1 1.3 JAK-STATs signaling pathway………………………………………….…. 3 1.4 Physiological functions of STAT3………………………………………..... 4 Part 2 Rationale and objectives………………………………………………….... 5 Chapter II Materials and Methods……………………………………….… 6 2.1 Mice………………………………………………………………………… 6 2.2 Preparation of mouse tail DNA and genotyping…………………………... 6 2.3 Western blot analysis………………………………………………….......... 7 2.4 Induction of mouse hepatitis………………………………………………. 8 2.5 Measurement of ALT and AST activities………………………………….. 8 2.6 Hematoxylin-eosin (H&E) staining of liver sections……………………..... 8 2.7 Caspase-3 activity assay………………………………………………….…. 8 2.8 Isolation of mouse intrahepatic leukocytes (IHL)……………………....…... 9 2.9 Antibodies and flow cytometric analysis………………………………..... 9 2.10 Quantitative real-time PCR……………………………………………….... 10 2.11 Hepatocytes preparation………………………………………………….... 11 2.12 Determination of cytokine-induced apoptotic hepatocytes………………... 12 2.13 Hepatic reactive oxygen species assay in liver tissue……………………... 12 Chapter III Results………………………………………………………….. 13 3.1 STAT3 is deleted in the liver but not in the spleen or thymus of ST3KO mice……………………………………………………………………………….. 13 3.2 Impaired elevation of ALT and AST levels in ST3KO mice after Con A treatment………………………………………………………………………….. 14 3.3 Decreased liver injury in ST3KO mice after Con A treatment……………... 15 3.4 Reduced apoptosis in the liver of ST3KO after Con A treatment…… ……. 15 3.5 Reduction of lethality in ST3KO mice after Con A treatment……................ 16 3.6 Comparable number and percentage of different subsets of IHLs in the liver effector cells in WT and ST3KO mice before and after Con A treatment…. 17 3.7 Comparable spleen injury in WT and ST3KO mice after Con A treatment... 19 3.8 Comparable levels of pro-inflammatory and anti-inflammatory cytokines in the liver of WT and ST3KO mice after Con A treatment……………………….. 20 3.9 IL-6 mediated enhancement of TNF-α-induced apoptosis in hepatocytes is STAT3-dependent………………………………………………………………... 21 3.10 Reduction by IFN-γ of TNF-α-induced caspase-3 activity in hepatocytes.. 23 3.11 Induction of Apex-1 is impaired in the liver of ST3KO mice in response to Con A treatment……………………………………………………………….. 24 3.12 Induction of SOCS3 is impaired but SOCS1 is prolonged in the liver of ST3KO mice in response to Con A treatment………………………………….... 25 Chapter IV Discussion………………………………………………………. 27 4.1 STAT3 is a positive but not a negative regulator for Con A-induced hepatitis…………………………………………………………………………… 27 4.2 Reduced TNF-α-induced apoptosis in ST3KO hepatocytes……..……….... 29 4.3 Prolonged SOCS1 induction but impaired SOCS3 induction in Con A-induced Hepatitis……………………………………………………………… 31 4.4 Evidence supports protection of ST3KO mice in Con A-induced Hepatitis.. 33 References…………………………………………………………….………...... 34 Figures……………………………………………………………......................... 44 | |
dc.language.iso | en | |
dc.title | STAT3在Con A引起肝炎反應中所扮演的角色的研究 | zh_TW |
dc.title | The Role of STAT3 in Con A-induced Hepatitis | en |
dc.type | Thesis | |
dc.date.schoolyear | 93-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 伍安怡,司徒惠康 | |
dc.subject.keyword | 肝炎, | zh_TW |
dc.subject.keyword | STAT3,Con A,hepatitis, | en |
dc.relation.page | 68 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2005-07-13 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 4.05 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。